Niloufar Kazemi
Research Subjects
Research Interests
Niloufar Kazemi has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Armin Bordbar
Department of Cardiology, Musavi Hospital, School of Medicine, Zanjan University of Medical Science, Zanjan, Iran
1 shared publication - Hadi Rezaeeyan
High Institute for Education and Research in Transfusion Medicine, Tehran, Iran
1 shared publication - Maryam Bakhshi
Islamic Azad University of Najaf Abad, Affiliated Hospitals, Isfahan, Iran
1 shared publication - Parisa Ghasemi
Research Committee, Medical School, Arak University of Medical Sciences, Arak, Iran
1 shared publication - Samaneh Salehipour Bavarsad
Cellular and Molecular Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
1 shared publication
Latest Publications
- 6 January 2024
- Published by Springer Nature in Molecular Biotechnology
- Vol. 66 (5) , 932-947
Molecular Insights into the Relationship Between Platelet Activation and Endothelial Dysfunction: Molecular Approaches and Clinical Practice
Platelets are one of the coagulation cells. When platelet activation occurs, many mediators are released and affect endothelial cells (ECs) and lead to endothelial dysfunction (ED). ED plays an important role in the pathogenesis of many diseases, including cardiovascular disease (CVD). Platelet are of important factors in ED. The release of mediators by platelets causes the stimulation of inflammatory pathways, oxidative stress, and apoptosis, which ultimately result in ED. On the other hand, platelet activation in CVD patients can be associated with a bad prognosis. Platelet activation can increase the level of markers such as p-selectin in the serum. Also, in this study, we have discussed the role of platelet as a diagnostic factor, as well as its use as a treatment option. In addition, we discussed some of the molecular pathways that are used to target platelet activation. Graphical Abstract
- 6 January 2024
- Published by Springer Nature in Molecular Biotechnology
- Vol. 66 (5) , 932-947
Molecular Insights into the Relationship Between Platelet Activation and Endothelial Dysfunction: Molecular Approaches and Clinical Practice
Platelets are one of the coagulation cells. When platelet activation occurs, many mediators are released and affect endothelial cells (ECs) and lead to endothelial dysfunction (ED). ED plays an important role in the pathogenesis of many diseases, including cardiovascular disease (CVD). Platelet are of important factors in ED. The release of mediators by platelets causes the stimulation of inflammatory pathways, oxidative stress, and apoptosis, which ultimately result in ED. On the other hand, platelet activation in CVD patients can be associated with a bad prognosis. Platelet activation can increase the level of markers such as p-selectin in the serum. Also, in this study, we have discussed the role of platelet as a diagnostic factor, as well as its use as a treatment option. In addition, we discussed some of the molecular pathways that are used to target platelet activation. Graphical Abstract